QualityStocksNewsBreaks Archives - Page 494 of 1520

FridayAug 05, 2022 12:42 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Gathers Leads at Events, Notes Rapid Market Expansion

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmetics, agrochem, and food/beverage industries, is reporting more than 60 strong leads gathered from its participation at two cannabis drink expo events, one in San Francisco and one in Chicago. The positive response is indicative of the rapid market expansion and potential for cannabis beverages, the company observes. Company officials also noted that a common theme at both events was the need for faster, more effective delivery of cannabis dosing with reliably repeatable precision.…

FridayAug 05, 2022 12:28 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Featured in Globe and Mail Article

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, was featured in a recent article published by The Globe and Mail. The piece, titled “Biogas has potential to play a role as Canada transitions from fossil fuels to renewable energy,” discusses the growing interest of utilities to embrace RNG. The growing demand is attributed to RNG’s “potential to play a sizable role in helping to reduce emissions of methane by capturing the climate-warming gas, rather than letting it spew into the atmosphere from landfills.” The publication highlights EverGen’s strategic acquisition of two-thirds of GrowTEC. Not only an…

ThursdayAug 04, 2022 1:14 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Research on Novel Liposomes

Silo Pharma (OTCQB: SILO) recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage Laboratories, a contract research organization (“CRO”). “Recent research by the company revealed that SPU-21 liposomes have the ability to target inflamed epithelium, suggesting they can be used to target drug delivery. Further, SPU-21 can potentially be used to develop fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis. According to the research, this approach may enhance therapeutic effects and decrease potential toxicity despite systemic administration of the drug,” a recent article reads. “In addition, Silo recently announced…

ThursdayAug 04, 2022 1:05 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Teaming up to Guide Commercial Real Estate Owners in Creating New Revenue Opportunities

Correlate Infrastructure Partners (OTCQB: CIPI) is a purpose-built energy use optimization company based in the United States. CIPI has made it its mission to develop green utility solutions for the commercial real estate industry to enable buildings and other corporate facilities to help contribute to a climate solution. “The company works to provide advisory assistance on acquisitions and project development to commercial solar industry clients and to back that up with development and financing resources for commercial clients looking for clean energy facility upgrades. CIPI’s subsidiaries, Correlate and Solar Site Design, use data analysis and a commitment to transparency to…

ThursdayAug 04, 2022 12:45 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) New Division Offers Full Suite of Mobile IoT Asset Management

SPYR (OTCQB: SPYR), dba SPYR Technologies, a diversified technology company developing products and leveraging the Internet of Things (“Iot”) for consumer use and large-scale applications and industries, and its subsidiary GeoTraq has completed a full suite of Mobile IoT asset management tools. The suite is designed to create significant return on investment (“ROI”) for enterprise customers in most industry verticals. According to the announcement, GeoTraq’s ultra-small tracker enables customers to deploy smart, connected technological accounting and monitoring devices within the IoT; the tracker features a proprietary blend of affordability, compatibility and efficiency offered under the GeoTraq label. According to the company, GeoTraq…

ThursdayAug 04, 2022 12:06 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Unveils New Corporate Website

Odyssey Health (OTC: ODYY), a company focused on developing unique, life-saving medical products, today announced the launch of its new corporate website. Consistent with the company’s recent name change, the new website was designed to better reflect Odyssey Health’s mission and focus while also improving communication strategies with current and potential shareholders, institutions, and various scientific and financial publications. “The launch of our new website is an important next step in the ongoing evolution of Odyssey and will enable us to provide more transparent communications with our shareholders and other stakeholders,” said Odyssey Health CEO Michael Redmond. “We are excited…

ThursdayAug 04, 2022 11:08 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Reaches Record Player Activity

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering mobile live-dealer technology to online gaming operators globally, has reached a corporate milestone. According to the company, its player activity continues to scale at the company's live dealer tables, and in July Playgon surpassed $82 million in player betting turnover, or more than $2.6 million per day. The company noted that this is a corporate best since it launched in May 2021. In addition, Playgon reported record monthly and daily bet spots, or wagers, of $2.85 million and $92,100 respectfully at the its VegasLounge(TM) tables. “We…

ThursdayAug 04, 2022 11:01 am

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Shares Validation Update on New Production System; Announces Dates for Webcast, Presales

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has begun the validation of its onsite, containerized green ammonia production system — ahead of schedule; in addition, the company announced that it will start accepting presales on Aug. 10, 2022. According to the announcement, critical milestones, such as the hiring of key team members and a move to a new facility, have been met as the company has prepared for the launch of its first demonstration pilot project. In addition, the company implemented a process in which each component is…

WednesdayAug 03, 2022 3:33 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Records First $9M Quarter

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, today announced it recorded record revenues exceeding $9 million in the third fiscal quarter ended July 31, 2022. According to the update, this represents an estimated 177% improvement on revenues of $3.25 million in the comparable year-ago quarter. “We are excited by meaningful progress and growth in both our B2B and B2C divisions,” said Golden Matrix CEO Brian Goodman. “The company has now recorded its first $9 million quarter, which is even more impressive when considering the impact of global economic headwinds and an…

WednesdayAug 03, 2022 2:34 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition of a phase 1 N,N-Dimethyltryptamine (“N,N-DMT”) study, the largest DMT study to date. The study provides key data relating to the company’s proprietary CYB004 substance with the potential to effectively treat anxiety disorders. “The phase 1 EBRX-101 study, now named CYB004-E, was acquired from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) FSE: 1XU1) through Cybin IRL Limited, Cybin’s wholly owned subsidiary… The adaptive, randomized, double-blinded, placebo-controlled, single-ascending-dose study produced notable results. According to the…

Site Search

Company Search

Category: QualityStocksNewsBreaks